Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Papillomavirus Infections 1 Hematologic Neoplasms 1 Carcinoma in Situ 1

Interventions

Cyclophosphamide 34 fludarabine 25 fludarabine phosphate 24 Tacrolimus 24 Mycophenolic Acid 23 Whole-Body Irradiation 22 Busulfan 15 Methotrexate 12 Melphalan 12 Granulocyte Colony-Stimulating Factor 12 Antilymphocyte Serum 12 thymoglobulin 11 Cyclosporine 11 Stem Cell Transplantation 10 Filgrastim 10 Rituximab 9 Thiotepa 7 Peripheral Blood Stem Cell Transplantation 7 Nivolumab 7 Dexamethasone 7 trametinib 6 Radiotherapy 6 Mesna 6 Cytarabine 6 Prednisone 5 Calcium Dobesilate 5 Bortezomib 5 Azacitidine 5 Alemtuzumab 5 Voriconazole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × Cell Count × Clear all

NCT01186809 2019-01-23

CIK2

A.O. Ospedale Papa Giovanni XXIII

Phase 2 Completed

74 enrolled 6 charts

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡